AMY RENFRO: Open Payments
NPI 1467935163 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 27 payments from 12 companies in 2025. Trend: 2023 $582 · 2024 $918 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Amgen Inc. | 4 | $90 |
| ABIOMED | 2 | $64 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Surmodics, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
Products named: LEQVIO, REPATHA, VERQUVO, Kerendia, Sublime 014 Rx PTA Balloon Dilatation Catheter, FARXIGA, NEXLETOL, LifeVest.
Industry payments across OK — which companies pay providers there.
